MIRA-15 is a next-generation sequencing (NGS) based diagnostic panel designed for the comprehensive detection of genetic mutations associated
NGS-based TARF panel detects key mutations in PIK3CA, KRAS, EGFR, BRAF, and ESR1 to support precision antitumor treatment decisions.
